{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:51:50Z","timestamp":1790794310603,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006260","name":"Technion-Israel Institute of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006260","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.semarthrit.2025.152764","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T19:26:21Z","timestamp":1749756381000},"page":"152764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Incidence of gout diagnosis among participants with hyperuricemia, insights from a nationwide cohort study"],"prefix":"10.1016","volume":"74","author":[{"given":"Shay","family":"Brikman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriel","family":"Perets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liel","family":"Serfaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Abuhasira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Schlesinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snait","family":"Ayalon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0395-4171","authenticated-orcid":false,"given":"Amir","family":"Bieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadav","family":"Rappoport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2025.152764_bib0001","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMcp2203385","article-title":"Gout","volume":"387","author":"Mikuls","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2025.152764_bib0002","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.9501","article-title":"Trends in prevalence of gout among US Asian adults, 2011-2018","volume":"6","author":"Yokose","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.semarthrit.2025.152764_bib0003","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/art.40807","article-title":"Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the national health and nutrition examination survey, 2007\u20132016","volume":"71","author":"Chen-Xu","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152764_bib0004","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0002-9343(87)90441-4","article-title":"Asymptomatic hyperuricemia. Risks and consequences in the normative aging study","volume":"82","author":"Campion","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2025.152764_bib0005","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/annrheumdis-2017-212288","article-title":"Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis","volume":"77","author":"Dalbeth","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2025.152764_bib0006","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1093\/rheumatology\/keae273","article-title":"A machine learning-based prediction model for gout in hyperuricemics: a nationwide cohort study","volume":"63","author":"Brikman","year":"2024","journal-title":"Rheumatol (U K)"},{"key":"10.1016\/j.semarthrit.2025.152764_bib0007","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/jama.2023.26640","article-title":"Serum urate and recurrent gout","volume":"331","author":"McCormick","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.semarthrit.2025.152764_bib0008","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152764_bib0009","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-021-01020-y","article-title":"Dietary and lifestyle-centered approach in gout care and prevention","volume":"23","author":"Yokose","year":"2021","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152764_bib0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ard.42.Suppl_1.12","article-title":"Studies of urate crystallisation in relation to gout","volume":"42","author":"Fiddis","year":"1983","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2025.152764_bib0011","article-title":"Hyperuricemia and its related diseases: mechanisms and advances in therapy","volume":"9","author":"Du","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.semarthrit.2025.152764_bib0012","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/acr.22336","article-title":"Medication adherence in gout: a systematic review","volume":"66","author":"De Vera","year":"2014","journal-title":"Arthritis Care Res (Hob)"},{"key":"10.1016\/j.semarthrit.2025.152764_bib0013","article-title":"Serum uric acid levels and prognosis of patients with non-alcoholic fatty liver disease","volume":"14","author":"Yang","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.semarthrit.2025.152764_bib0014","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5470739","article-title":"Diabetes mellitus is associated with a lower risk of gout: a meta-analysis of observational studies","volume":"2020","author":"Li","year":"2020","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.semarthrit.2025.152764_bib0015","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/jama.2022.11390","article-title":"Association between Gout flare and subsequent cardiovascular events among patients with Gout","volume":"328","author":"Cipolletta","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.semarthrit.2025.152764_bib0016","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/art.42381","article-title":"Altered risk of incident gout according to changes in metabolic syndrome status: a nationwide, population-based cohort study of 1.29 million young men","volume":"75","author":"Eun","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152764_bib0017","article-title":"Weight loss after receiving anti-obesity medications and gout among individuals with overweight and obese: a population-based cohort study","author":"Wei","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152764_bib0018","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamainternmed.2024.0376","article-title":"Sodium-glucose cotransporter-2 inhibitors vs sulfonylureas for gout prevention among patients with type 2 diabetes receiving metformin","volume":"184","author":"McCormick","year":"2024","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.semarthrit.2025.152764_bib0019","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.30885","article-title":"Gout flares and mortality after sodium-glucose cotransporter-2 inhibitor treatment for Gout and type 2 diabetes","volume":"6","author":"Wei","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152764_bib0020","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/annrheumdis-2021-221635","article-title":"Impact of adiposity on risk of female gout among those genetically predisposed: sex-specific prospective cohort study findings over >32 years","volume":"81","author":"McCormick","year":"2022","journal-title":"Ann Rheum Dis [Internet]"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152764_bib0021","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1002\/art.42613","article-title":"Body mass index and the risk of rheumatic disease: linear and nonlinear mendelian randomization analyses","volume":"75","author":"Karlsson","year":"2023","journal-title":"Arthritis Rheumatol [Internet]"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152764_bib0022","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/art.1780380508","article-title":"Racial differences in the incidence of gout. the role of hypertension","volume":"38","author":"Hochberg","year":"1995","journal-title":"Arthritis Rheum [Internet]"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225001350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225001350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T06:01:05Z","timestamp":1780120865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017225001350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":22,"alternative-id":["S0049017225001350"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152764","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of gout diagnosis among participants with hyperuricemia, insights from a nationwide cohort study","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152764"}}